subscribe

Alan Evans receives Order of Canada

Career of breakthroughs in neuroimaging recognized with one of the nation’s highest honours

A career that took an uncharted trajectory has been recognized with the Order of Canada, one of the country’s top honours.

Published: 30 Jun 2025

AI analysis of healthcare records reveals key factors in autism diagnosis

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Email address:
Published: 26 Mar 2025

Latest Alzheimer’s drug shown less effective in females than males

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.

Published: 18 Mar 2025

Project to create AI model for ALS receives Génome Québec funding

$400,000 will fuel public-private collaboration to discover new disease biomarkers

 

Published: 17 Mar 2025

Prescribing anti-swelling drug reduces immune response weeks after last dose

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy

 

Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.

Email address:
Published: 26 Feb 2025

Six principal investigators from The Neuro receive CIHR grants

Projects include important research on Parkinson’s, glioblastoma and dementia

 

Published: 10 Feb 2025

An open solution to improving research reproducibility

Academic and industry scientists collaborate on a new method to characterize research antibodies

Structural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McGill University, in collaboration with scientists from 11 major antibody manufacturers representing approximately 80 per cent of global renewable antibody production, have developed and standardized an Open Science platform to characterize research antibodies.

Published: 18 Dec 2024

At-home neurological disorder diagnosis project receives major funding

$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson’s disease

REM sleep behaviour disorder (RBD) is an often debilitating condition that causes people to act out in their sleep, sometimes violently. What’s worse, people with the disorder often go on to develop Parkinson’s disease.

Published: 8 Nov 2024

Research on new stem cell models receives $2.6 million

Thomas Durcan’s project will dissect the role of microglia in degenerative conditions, to identify new therapeutic strategies for Alzheimer's treatment

An innovative new program based at The Neuro has received $2.6 million from the CQDM and the Brain Canada Foundation.

Published: 16 Oct 2024

Bilingualism makes the brain more efficient, especially when learned at a young age

MRI data from large sample shows increased whole-brain connectivity in people with a second language

Neuroplasticity is the brain’s ability to build connections within itself, adapting to the surrounding environment. The brain is most plastic in childhood, forming new pathways in reaction to stimuli such as language.

Email address:
Published: 11 Oct 2024

Recreating a hallmark of Parkinson's disease in human neurons

Scientists use stem cells to follow development of protein bodies characteristic of neurological disease

Lewy bodies are a hallmark of Parkinson's disease (PD) and other related neurological conditions. Understanding why and how they develop is critical to developing better treatments.

Email address:
Published: 8 Oct 2024

Alan Evans elected Fellow of the Royal Society

Honour is recognition for a lifetime of leading research

Alan Evans, a researcher at The Neuro, James McGill Professor of Neurology and Neurosurgery and co-director of the Ludmer Centre for Neuroinformatics and Mental Health, has been elected to the Fellowship of the Royal Society, joining a class of scientists that includes a Nobel laureate and a former Chief Medical Advisor to the US President.  

Published: 17 Jun 2024

Two Neuro projects funded by international partnership

Researchers will study how hormones affect brain cancer and the role of neural circuits in social skills

The Paris Brain Institute and the Institut Pasteur have partnered with The Neuro to fund two groundbreaking studies, each receiving more than $440,000. These projects are part of an international collaboration to address future challenges in neuroscience.

Published: 14 Jun 2024

$10.6M grant supports innovative autism project

McGill Translational Platform in Autism Research will help uncover the disorders’ neural foundations

 

A new project at The Neuro, McGill University and the Research Institute of the McGill University Health Centre (RI-MUHC) has been awarded $10.6M in financial support as part of the Canada Foundation for Innovation’s (CFI) Innovation Fund.

Published: 8 Apr 2024

Making AI a partner in neuroscientific discovery

New paper argues that Large Language Models can reveal breakthroughs humans alone cannot

The past year has seen major advances in Large Language Models (LLMs) such as ChatGPT. The ability of these models to interpret and produce human text sources (and other sequence data) has implications for people in many areas of human activity.

Email address:
Published: 9 Feb 2024

Pages

The Neuro logo McGill logoMcGill University Health Centre logoKillam Laureates

 

The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.

 

 

Facebook instagram blue sky iconx, formerly known as twitter linkedIn youtube

Back to top